IRIS UniCatt

Cingolani, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.577
NA - Nord America 2.528
AS - Asia 1.261
SA - Sud America 333
AF - Africa 73
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.434
DE - Germania 554
IT - Italia 524
SE - Svezia 478
SG - Singapore 466
CN - Cina 371
BR - Brasile 303
FR - Francia 232
GB - Regno Unito 151
IE - Irlanda 136
UA - Ucraina 133
FI - Finlandia 91
ID - Indonesia 82
IN - India 77
PL - Polonia 65
RU - Federazione Russa 59
CA - Canada 58
TR - Turchia 37
BE - Belgio 32
NL - Olanda 30
AT - Austria 28
HK - Hong Kong 27
IR - Iran 24
AU - Australia 22
KR - Corea 21
SA - Arabia Saudita 20
MX - Messico 19
VN - Vietnam 19
PH - Filippine 14
PK - Pakistan 14
BD - Bangladesh 13
AR - Argentina 12
EG - Egitto 12
MA - Marocco 11
MY - Malesia 11
CI - Costa d'Avorio 10
IQ - Iraq 10
JP - Giappone 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
KE - Kenya 9
CH - Svizzera 8
LT - Lituania 8
ZA - Sudafrica 8
PT - Portogallo 6
EE - Estonia 5
GR - Grecia 5
IL - Israele 5
NG - Nigeria 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EU - Europa 4
LV - Lettonia 4
RO - Romania 4
TW - Taiwan 4
BZ - Belize 3
EC - Ecuador 3
ES - Italia 3
JO - Giordania 3
KG - Kirghizistan 3
NO - Norvegia 3
PE - Perù 3
SD - Sudan 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
CL - Cile 2
CM - Camerun 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.800
Salva come PNG Salva come JPEG
Città #
Chandler 486
Singapore 267
Ashburn 183
Rome 138
Dublin 133
New York 125
Jacksonville 88
Jakarta 81
San Mateo 80
The Dalles 68
Milan 67
Nanjing 67
Ann Arbor 61
Wilmington 57
Redmond 51
Chicago 49
Dearborn 46
Princeton 46
Helsinki 45
Kraków 45
Moscow 39
Boston 37
Bremen 34
Marseille 33
Boardman 32
North Bergen 32
Frankfurt am Main 30
Brussels 28
Cattolica 28
London 28
Nuremberg 28
Los Angeles 26
Woodbridge 26
Munich 24
Nürnberg 24
Hefei 23
Nanchang 23
Izmir 22
São Paulo 21
Hong Kong 20
Houston 20
Ottawa 20
Redwood City 20
Seoul 20
Beijing 19
Lawrence 18
Fairfield 17
Düsseldorf 16
Lancaster 16
Guangzhou 15
Kunming 15
Seattle 15
Norwalk 14
San Jose 14
Pune 13
Fremont 12
Amsterdam 11
Augusta 11
Dammam 11
Lauterbourg 11
Turku 11
University Park 11
Vienna 11
Wroclaw 11
Abidjan 10
Bexley 10
Kish 10
Mountain View 10
Rio de Janeiro 10
San Francisco 10
Washington 10
Changsha 9
Council Bluffs 9
Edinburgh 9
Shenyang 9
Cairo 8
Hanoi 8
Paris 8
Sydney 8
Tianjin 8
Zurich 8
Al Qatif 7
Hangzhou 7
Ho Chi Minh City 7
Hyderabad 7
Portsmouth 7
Tokyo 7
Toronto 7
Zhengzhou 7
Belo Horizonte 6
Brooklyn 6
Falkenstein 6
Hebei 6
Lahore 6
Oggiono 6
Phoenix 6
Roubaix 6
Shanghai 6
Warsaw 6
Betim 5
Totale 3.368
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 457
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 235
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 184
Plasma levels of Interleukin-6 and Interleukin-10 in preterm neonates evaluated for sepsis 151
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 149
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 138
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 134
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 132
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 125
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 123
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 122
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 120
Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review. 114
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 114
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 110
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 108
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis 105
Residual respiratory impairment after COVID-19 pneumonia 102
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure 99
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 97
Sarilumab use in severe SARS-CoV-2 pneumonia 97
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 92
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 90
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 89
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 89
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 88
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy 87
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 86
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 86
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 86
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients 84
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy 84
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 82
Residual respiratory impairment after COVID-19 pneumonia 81
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 80
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 79
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital 79
Interpretation systems for genotypic drug resistance of HIV-1 78
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 78
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 78
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 77
Malnutrition in COVID-19 survivors: prevalence and risk factors 75
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 73
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 73
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 72
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 71
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study 70
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 69
COVID-19 atypical Parsonage-Turner syndrome: a case report 65
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 64
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting 63
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 63
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 63
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition 62
Clinical implications of HIV-1 drug resistance in the neurological compartment 61
[Treating HIV disease: back to the patient?] 61
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 59
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 58
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure. 57
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 55
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 54
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials 54
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 53
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry 52
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 52
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 52
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: Data from the ICONA foundation study group, years 1997-2013 52
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 48
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 45
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 45
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 44
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 43
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 42
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 42
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 40
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 37
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective 37
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 33
Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023: preliminary investigation 32
Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin 24
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 23
Is the rate of virological failure to cART continuing to decline in recent calendar years? 21
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study 20
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022 16
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 15
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 13
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 9
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 3
Totale 6.924
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 0 34
2020/2021376 19 31 9 30 31 23 34 14 67 24 77 17
2021/2022669 53 44 14 41 32 20 12 99 33 54 110 157
2022/20231.824 190 187 182 335 175 233 86 97 185 70 63 21
2023/2024929 42 198 37 52 40 167 67 36 22 61 83 124
2024/20251.901 36 52 126 102 144 95 138 92 321 192 393 210
Totale 6.924